TLT.V - Theralase Technologies Inc.

TSXV - TSXV Delayed Price. Currency in CAD
0.3150
+0.0100 (+3.28%)
At close: 3:58PM EST
Stock chart is not supported by your current browser
Previous Close0.3050
Open0.3050
Bid0.310 x 0
Ask0.315 x 0
Day's Range0.3050 - 0.3200
52 Week Range0.1900 - 0.4600
Volume69,860
Avg. Volume147,396
Market Cap43.776M
Beta (3Y Monthly)1.50
PE Ratio (TTM)N/A
EPS (TTM)-0.030
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.38
  • ACCESSWIRElast month

    Health Canada Grants ITA Approval to Commence Phase II Clinical Study

    TORONTO, ON / ACCESSWIRE / December 10, 2018 / Theralase Technologies Inc.(" Theralase® " or the " Company ") ( TSXV: TLT ) ( OTCQB: TLTFF ), a clinical stage pharmaceutical company ...

  • Baystreet2 months ago

    Stocks in play: Theralase Technologies Inc.

    Announced today that Theralase's Rutherrin® Photo Dynamic Therapy has been shown to increase its efficacy ...

  • ACCESSWIRE2 months ago

    Theralase(R) Granted Canadian Anti-Cancer Patent

    Theralase Granted Canadian Patent for Metal-Glycoprotein Complexes Used to Hunt Cancer Cells and When Laser Light Activated Destroy Them TORONTO, ON / ACCESSWIRE / November 15, 2018 / Theralase Technologies ...

  • ACCESSWIRE2 months ago

    Patient Five Cancer-Free After Single PDT Treatment

    Theralase Provides Update on 9 Months Post Treatment Cystoscopy Analysis TORONTO, ONTARIO / ACCESSWIRE / November 8, 2018 / Theralase Technologies Inc. (" Theralase® " or the " Company ")( ...

  • Newsfile6 months ago

    BTV Reveals Novel Cancer Treatment, Cannabis and Lithium Companies

    Vancouver, British Columbia--(Newsfile Corp. - July 26, 2018) - On BNN Sat July 28 & Sun July 29, 2018 - BTV-Business Television goes on location with four small cap companies in popular sectors. Full EpisodeBlissCo Cannabis Corp. (CSE: BLIS) — BTV shares how this CEO's distribution background will help his company profit in the rapidly expanding cannabis market. See Feature  Critical Elements Corp. (TSXV: CRE) (OTCQX: CRECF) — Electric vehicle demand spells opportunity for the key ...

  • ACCESSWIRE9 months ago

    Today’s Research Reports on Eyecarrot Innovations, Antibe Therapeutics, Emblem and Theralase Technologies

    NEW YORK, NY / ACCESSWIRE / April 20, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...

  • ACCESSWIRE9 months ago

    Canadian Exchanges Stock Scanner Titan Medical, Patient Home Monitoring, Zecotek Photonics, and Theralase Technologies

    LONDON, UK / ACCESSWIRE / April 19, 2018 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Medical Devices industry: Titan Medical, Patient Home Monitoring, Zecotek Photonics, and Theralase Technologies. The TSX Venture Exchange gained 5.05 points, or 0.63%, to finish at 802.60. Today's stocks of interest consist of: Titan Medical Inc. (TSX: TMD), Patient Home Monitoring Corporation (TSX-V: PHM), Zecotek Photonics Inc. (TSX-V: ZMS), and Theralase Technologies Inc. (TSX-V: TLT).